Resume

The Michael J Fox Foundation for Parkinson's Research invites applications for its target optimisation awards.

These aim to support collaborative, multi-institutional teams to build more robust datasets that can validate targets within a specific, prioritised biological pathway as defined by MJFF scientific staff.

Teams should develop and execute systematic, milestone-driven projects using complementary experimental strategies and, where appropriate, cross-team replication. For the fall 2015 funding cycle, MJFF has identified targets involved in cellular protein handling as a priority for further validation and optimisation. Examples of targets appropriate for this program include: LAMP-2A, NEDD-4, TFEB and VPS35. Preference will be given to proposals utilising experimental systems with high construct and predictive validity to human PD such as patient-derived material or animal models utilising clinically translatable endpoints.

Applications may be submitted by biotechnology or pharmaceutical companies and publicly or privately held for-profit and non-profit entities throughout the world. Postdoctoral fellows are not eligible to act as principal investigator.

Funding

Two-year grants of up to US$400,000, inclusive of both direct and indirect costs, are available. No more than 10 per cent of direct costs for for-profit institutions may go to indirect costs

How to apply

https://www.grantrequest.com/SID_592/Default.asp?SA=SNA&FID=35183

In case of interest, please contact with FSJD Research's Dpt. no later than May 18th.